|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu C, Chen F, Wang X, Cai Z, Yang M, Zhong
Q, Feng J, Li J, Shen C and Wen Z: Pin2 telomeric repeat factor
1-interacting telomerase inhibitor 1 (PinX1) inhibits
nasopharyngeal cancer cell stemness: Implication for cancer
progression and therapeutic targeting. J Exp Clin Cancer Res.
39:312020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okudela K, Matsumura M, Arai H and Woo T:
The nonsmokers' and smokers' pathways in lung adenocarcinoma:
Histological progression and molecular bases. Cancer Sci. Jun
18–2021.(Epub ahead of print). doi: 10.1111/cas.15031. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seow WJ, Shu XO, Nicholson JK, Holmes E,
Walker DI, Hu W, Cai Q, Gao YT, Xiang YB, Moore SC, et al:
Association of untargeted urinary metabolomics and lung cancer risk
among never-smoking women in China. JAMA Netw Open. 2:e19119702019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aggarwal C, Somaiah N and Simon G:
Antiangiogenic agents in the management of non-small cell lung
cancer: Where do we stand now and where are we headed? Cancer Biol
Ther. 13:247–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rivera LB and Bergers G: CANCER. Tumor
angiogenesis, from foe to friend. Science. 349:694–695. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Abboodi M, An R, Weber M, Schmid R,
Klausing A, Horch RE, Boos AM and Kengelbach-Weigand A: Tumor type
dependent effects on the angiogenic abilities of endothelial cells
in an in vitro rat cell model. Oncol Rep. 42:350–360.
2019.PubMed/NCBI
|
|
10
|
Perut F, Roncuzzi L, Zini N, Massa A and
Baldini N: Extracellular nanovesicles secreted by human
osteosarcoma cells promote angiogenesis. Cancers (Basel).
11:7792019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghorbanian M, Babashah S and Ataei F: The
effects of ovarian cancer cell-derived exosomes on vascular
endothelial growth factor expression in endothelial cells. EXCLI J.
18:899–907. 2019.PubMed/NCBI
|
|
12
|
Li N: Platelets in cancer metastasis: To
help the ‘villain’ to do evil. Int J Cancer. 138:2078–2087. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiodoni C, Iezzi M, Guiducci C,
Sangaletti S, Alessandrini I, Ratti C, Tiboni F, Musiani P, Granger
DN and Colombo MP: Triggering CD40 on endothelial cells contributes
to tumor growth. J Exp Med. 203:2441–2450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gay LJ and Felding-Habermann B:
Contribution of platelets to tumour metastasis. Nat Rev Cancer.
11:123–134. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Borsig L: The role of platelet activation
in tumor metastasis. Expert Rev Anticancer Ther. 8:1247–1255. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim HK, Song KS, Chung JH, Lee KR and Lee
SN: Platelet microparticles induce angiogenesis in vitro. Br J
Haematol. 124:376–384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Vito C, Navone SE, Marfia G, Abdel Hadi
L, Mancuso ME, Pecci A, Crisà FM, Berno V, Rampini P, Campanella R,
et al: Platelets from glioblastoma patients promote angiogenesis of
tumor endothelial cells and exhibit increased VEGF content and
release. Platelets. 28:585–594. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li R, Ren M, Chen N, Luo M, Deng X, Xia J,
Yu G, Liu J, He B, Zhang X, et al: Presence of intratumoral
platelets is associated with tumor vessel structure and metastasis.
BMC Cancer. 14:1672014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Campanella R, Guarnaccia L, Cordiglieri C,
Trombetta E, Caroli M, Carrabba G, La Verde N, Rampini P, Gaudino
C, Costa A, et al: Tumor-educated platelets and angiogenesis in
glioblastoma: Another brick in the wall for novel prognostic and
targetable biomarkers, changing the vision from a localized tumor
to a systemic pathology. Cells. 9:2942020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haemmerle M, Stone RL, Menter DG,
Afshar-Kharghan V and Sood AK: The platelet lifeline to cancer:
Challenges and opportunities. Cancer Cell. 33:965–983, 2018.21.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carrim N, Arthur JF, Hamilton JR, Gardiner
EE, Andrews RK, Moran N, Berndt MC and Metharom P: Thrombin-induced
reactive oxygen species generation in platelets: A novel role for
protease-activated receptor 4 and GPIbα. Redox Biol. 6:640–647.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mercatali L, La Manna F, Miserocchi G,
Liverani C, De Vita A, Spadazzi C, Bongiovanni A, Recine F, Amadori
D, Ghetti M, et al: Tumor-stroma crosstalk in bone tissue: The
osteoclastogenic potential of a breast cancer cell line in a
co-culture system and the role of EGFR inhibition. Int J Mol Sci.
18:E16552017. View Article : Google Scholar
|
|
23
|
Kraya R, Komin A and Searson P: On chip
bioelectric impedance spectroscopy reveals the effect of
p-glycoprotein efflux pumps on the paracellular impedance of tight
junctions at the blood-brain barrier. IEEE Trans Nanobioscience.
15:697–703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
LI S, CHEN ZB, LÜ M and ZHU Y: Current
status and future of drugs targeting platelets-tumor cells
interactions. Yao Xue Xue Bao. 2:360–367. 2021.(In Chinese).
|
|
25
|
Mazurek A, Luo W, Krasnitz A, Hicks J,
Powers RS and Stillman B: DDX5 regulates DNA replication and is
required for cell proliferation in a subset of breast cancer cells.
Cancer Discov. 2:812–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jain RK: Antiangiogenesis strategies
revisited: From starving tumors to alleviating hypoxia. Cancer
Cell. 26:605–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang YF, Meng YY, Ye J, Xia XJ, Li L, Dong
WJ, Wang HL and Liu YL: Co-culture of human breast adenocarcinoma
cells and human umbilical vein endothelial cells to mimic in vivo
tumor microenvironment. Yao Xue Xue Bao. 3:403–409. 2018.(In
Chinese).
|
|
28
|
Khan KA and Kerbel RS: Improving
immunotherapy outcomes with anti-angiogenic treatments and vice
versa. Nat Rev Clin Oncol. 15:310–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin X, Qiu W, Xiao Y, Ma J, Xu F, Zhang K,
Gao Y, Chen Q, Li Y, Li H, et al: MiR-199b-5p suppresses tumor
angiogenesis mediated by vascular endothelial cells in breast
cancer by targeting ALK1. Front Genet. 10:13972020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ishihara S, Onoda N, Noda S, Asano Y,
Tauchi Y, Morisaki T, Kashiwagi S, Takashima T and Ohira M:
Sorafenib inhibits vascular endothelial cell proliferation
stimulated by anaplastic thyroid cancer cells regardless of BRAF
mutation status. Int J Oncol. 55:1069–1076. 2019.PubMed/NCBI
|
|
31
|
Kaneda H, Arao T, Matsumoto K, De Velasco
MA, Tamura D, Aomatsu K, Kudo K, Sakai K, Nagai T, Fujita Y, et al:
Activin A inhibits vascular endothelial cell growth and suppresses
tumour angiogenesis in gastric cancer. Br J Cancer. 105:1210–1217.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo D, Xu S, Wang N, Jiang H, Huang Y, Jin
X, Xue B, Zhang C and Zhu X: Prodrug-embedded angiogenic
vessel-targeting nanoparticle: A positive feedback amplifier in
hypoxia-induced chemo-photo therapy. Biomaterials. 144:188–198.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Frezzetti D, Gallo M, Roma C, D'Alessio A,
Maiello MR, Bevilacqua S, Normanno N and De Luca A: Vascular
endothelial growth factor a regulates the secretion of different
angiogenic factors in lung cancer cells. J Cell Physiol.
231:1514–1521. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Carmeliet P and Jain RK: Principles and
mechanisms of vessel normalization for cancer and other angiogenic
diseases. Nat Rev Drug Discov. 10:417–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jain RK: Normalization of tumor
vasculature: An emerging concept in antiangiogenic therapy.
Science. 307:58–62. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nagy JA, Chang SH, Shih SC, Dvorak AM and
Dvorak HF: Heterogeneity of the tumor vasculature. Semin Thromb
Hemost. 36:321–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mierke CT: Cancer cells regulate
biomechanical properties of human microvascular endothelial cells.
J Biol Chem. 286:40025–40037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schumacher D, Strilic B, Sivaraj KK,
Wettschureck N and Offermanns S: Platelet-derived nucleotides
promote tumor-cell transendothelial migration and metastasis via
P2Y2 receptor. Cancer Cell. 24:130–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang X, Hu J, Wu Z, Cafarello ST, Di
Matteo M, Shen Y, Dong X, Adler H, Mazzone M, Ruiz de Almodovar C,
et al: Protein phosphatase 2A mediates YAP activation in
endothelial cells upon VEGF stimulation and matrix stiffness. Front
Cell Dev Biol. 9:6755622021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Behnammanesh G, Durante ZE, Peyton KJ,
Martinez-Lemus LA, Brown SM, Bender SB and Durante W: Canagliflozin
inhibits human endothelial cell proliferation and tube formation.
Front Pharmacol. 10:3622019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pipili-Synetos E, Papadimitriou E and
Maragoudakis ME: Evidence that platelets promote tube formation by
endothelial cells on matrigel. Br J Pharmacol. 125:1252–1257. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wassmer SC, Taylor T, Maclennan CA,
Kanjala M, Mukaka M, Molyneux ME and Grau GE: Platelet-induced
clumping of Plasmodium falciparum-infected erythrocytes from
Malawian patients with cerebral malaria-possible modulation in vivo
by thrombocytopenia. J Infect Dis. 197:72–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lin WF, Lu JY, Cheng BB and Ling CQ:
Progress in research on the effects of traditional Chinese medicine
on the tumor microenvironment. J Integr Med. 15:282–287. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li Q, Chen Y, Zhao D, Yang S, Zhang S, Wei
Z, Wang Y, Qian K, Zhao B, Zhu Y, et al: LongShengZhi Capsule
reduces carrageenan-induced thrombosis by reducing activation of
platelets and endothelial cells. Pharmacol Res. 144:167–180. 2019.
View Article : Google Scholar : PubMed/NCBI
|
